D-0389-2019 Class II Terminated
FDA drug recall D-0389-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 15, 2019 and is designated Class II. Reason for recall: Presence of Foreign Substance: Product complaint of black speckles observed on tablets. The recall status is terminated (terminated Mar 3, 2020). Affected quantity: 118 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 30, 2019
- Initiation Date
- Jan 15, 2019
- Termination Date
- Mar 3, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 118 bottles
Product description
Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10
Reason for recall
Presence of Foreign Substance: Product complaint of black speckles observed on tablets.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 43E021 and 43E023, Exp. 01/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0389-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026